Literature DB >> 22818413

Cardiac-sparing whole lung IMRT in children with lung metastasis.

John A Kalapurakal1, Yunkai Zhang, Alan Kepka, Brian Zawislak, Vythialingam Sathiaseelan, Cynthia Rigsby, Mahesh Gopalakrishnan.   

Abstract

PURPOSE: To demonstrate the dosimetric advantages of cardiac-sparing (CS) intensity modulated radiation therapy (IMRT) in children undergoing whole lung irradiation (WLI). METHODS AND MATERIALS: Chest CT scans of 22 children who underwent simulation with 3-dimensional (n=10) or 4-dimensional (n=12) techniques were used for this study. Treatment planning was performed using standard anteroposterior-posteroanterior (S-RT) technique and CS-IMRT. Left and right flank fields were added to WLI fields to determine whether CS-IMRT offered any added protection to normal tissues at the junction between these fields. The radiation dose to the lung PTV, cardiac structures, liver, and thyroid were analyzed and compared.
RESULTS: CS-IMRT had 4 significant advantages over S-RT: (1) superior cardiac protection (2) superior 4-dimensional lung planning target volume coverage, (3) superior dose uniformity in the lungs with fewer hot spots, and (4) significantly lower dose to the heart when flank RT is administered after WLI.
CONCLUSIONS: The use of CS-IMRT and 4-dimensional treatment planning has the potential to improve tumor control rates and reduce cardiac toxicity in children receiving WLI.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22818413     DOI: 10.1016/j.ijrobp.2012.05.036

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  7 in total

1.  Cardiac-Sparing Whole Lung IMRT in Patients With Pediatric Tumors and Lung Metastasis: Final Report of a Prospective Multicenter Clinical Trial.

Authors:  John A Kalapurakal; Mahesh Gopalakrishnan; David O Walterhouse; Cynthia K Rigsby; Alfred Rademaker; Irene Helenowski; Sandy Kessel; Karen Morano; Fran Laurie; Ken Ulin; Natia Esiashvili; Howard Katzenstein; Karen Marcus; David S Followill; Suzanne L Wolden; Anita Mahajan; Thomas J Fitzgerald
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-08-29       Impact factor: 7.038

2.  Therapy-Related Cardiac Risk in Childhood Cancer Survivors: An Analysis of the Childhood Cancer Survivor Study.

Authors:  James E Bates; Rebecca M Howell; Qi Liu; Yutaka Yasui; Daniel A Mulrooney; Sughosh Dhakal; Susan A Smith; Wendy M Leisenring; Daniel J Indelicato; Todd M Gibson; Gregory T Armstrong; Kevin C Oeffinger; Louis S Constine
Journal:  J Clin Oncol       Date:  2019-03-12       Impact factor: 44.544

Review 3.  Children's Oncology Group's 2013 blueprint for research: radiation oncology.

Authors:  Thomas E Merchant; David Hodgson; Nadia N I Laack; Suzanne Wolden; Danny J Indelicato; John A Kalapurakal
Journal:  Pediatr Blood Cancer       Date:  2012-12-19       Impact factor: 3.167

4.  Heart-sparing volumetric modulated arc therapy for whole lung irradiation.

Authors:  Alexandros Papachristofilou; Anna-Lena Hottinger; Oliver Weinhold; Yasar-Kemal Avcu; Tobias Finazzi; Tamara Diesch; Ulrich Schratzenstaller
Journal:  Strahlenther Onkol       Date:  2018-09-06       Impact factor: 3.621

Review 5.  Advances in radiotherapy technology for pediatric cancer patients and roles of medical physicists: COG and SIOP Europe perspectives.

Authors:  Chia-Ho Hua; Anthony E Mascia; Enrica Seravalli; Antony J Lomax; Klaus Seiersen; Kenneth Ulin
Journal:  Pediatr Blood Cancer       Date:  2021-05       Impact factor: 3.167

6.  Whole Lung Irradiation in Adults with Metastatic Ewing Sarcoma: Practice Patterns and Implications for Treatment.

Authors:  Shyam K Tanguturi; Suzanne George; Karen J Marcus; George D Demetri; Elizabeth H Baldini
Journal:  Sarcoma       Date:  2015-06-25

7.  A New Proton Therapy Solution Provides Superior Cardiac Sparing Compared With Photon Therapy in Whole Lung Irradiation for Pediatric Tumor Patients.

Authors:  Xue Sha; Jinghao Duan; Xiutong Lin; Jian Zhu; Ruohui Zhang; Tao Sun; Hui Wang; Xiangjuan Meng; Yong Yin
Journal:  Front Oncol       Date:  2021-02-02       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.